United States securities and exchange commission logo





                          September 26, 2022

       John J. Harrington
       Partner
       Baker & Hostetler LLP
       Key Tower, 127 Public Square
       Suite 200
       Cleveland, OH 44114

                                                        Re: AIM ImmunoTech Inc.
                                                            Preliminary Proxy
Statement filed by Jonathan Jorgl et al.
                                                            Filed September 23,
2022
                                                            File No. 001-27072

       Dear Mr. Harrington:

              We have reviewed your filing and have the following comment. In
our comment, we may
       ask you to provide us with information so we may better understand your
disclosure.

               Please respond to this comment by providing the requested
information or advise us as
       soon as possible when you will respond. If you do not believe our
comment applies to your facts
       and circumstances, please tell us why in your response.

                                                        After reviewing your
response to this comment, we may have additional comments.

       PRRN14A filed on September 23, 2022

       General

   1.                                                   We note your response
to Comment 3. We do not necessarily agree with your analysis or
                                                        conclusion but have no
further comment at this time.
               We remind you that the filing persons are responsible for the
accuracy and adequacy of
       their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.

              Please direct any questions to Michael Killoy at 202-551-7576 or
Christina Chalk at 202-
       551-3263.
 John J. Harrington
Baker & Hostetler LLP
September 26, 2022
Page 2

FirstName LastNameJohn J. Harrington   Sincerely,
Comapany NameBaker & Hostetler LLP
                                       Division of Corporation Finance
September 26, 2022 Page 2              Office of Mergers & Acquisitions
FirstName LastName